BioSpace News Archive

Business

Moderna Surges into 2022 with Carisma CAR-M Partnership

Moderna roared through 2021 on the strength of its COVID-19 vaccine and that momentum is continuing in 2022.

January 10, 2022
·
3 min read
·
Alex Keown
Business

Bayer Strikes “Mammoth” CRISPR Deal to Bolster Cell and Gene Therapy

Bayer and Mammoth Biosciences forged a strategic collaboration potentially valued at more than $1 billion. The partnership grants Bayer access to Mammoth’s CRISPR technology to develop in vivo gene-editing therapies.

January 10, 2022
·
2 min read
·
Alex Keown
FDA

U.S. Averaging 700K New COVID-19 Cases Daily as Deltacron Revealed

The U.S. averages more than 700,000 new COVID-19 cases per day. As of Saturday, there were 4.91M cases, more cases in seven days than in April, May, June, and July 2021 combined.

January 10, 2022
·
5 min read
·
Mark Terry
Business

Acadia and Stoke Team Up Against Neurodevelopmental Diseases

The collaboration covers several neurodevelopmental targets, including Rett syndrome, SYNGAP1 syndrome, and one other disease yet to be disclosed.

January 10, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Allogene’s AlloCAR T Trials are Full Speed Ahead as FDA Lifts Hold

Allogene announced that the chromosomal abnormality was not detected in any manufactured AlloCAR T product or any patient treated with the same lot of drugs.

January 10, 2022
·
2 min read
·
Alex Keown
Biomedical Warming and Thawing Devices Market in 2022 - Detailed Analysis Report

As per the WHO, injuries caused by traffic collisions, falls, burns, and poisoning are responsible for around 9% of deaths worldwide.

January 10, 2022
·
5 min read
Vision Care Market Detailed Analysis and Forecast to 2028

World over, vision care has made some significant advances on the adoption of new population health approaches, especially in developed countries, underpinning the evolution of the vision care market.

January 10, 2022
·
6 min read
Business

OpGen Announces Preliminary Unaudited Revenue for Fiscal 2021 and Provides Business Update

OpGen, Inc., a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced that total preliminary unaudited revenue for OpGen in 2021 was approximately $4.3 million, compared to approximately $4.2 million in 2020.

January 10, 2022
·
6 min read
BioMidwest

Surgery Partners Reaffirms 2021 and 2022 Full Year Guidance; David T. Doherty to Assume Role of Chief Financial Officer on February 1, 2022

Members of management of Surgery Partners, Inc., a leading short-stay surgical facility owner and operator, will be meeting with investors , January 10, 2022, as part of the 40th Annual J.P. Morgan Healthcare Conference, including a virtual presentation at 5:15 p.m. ET.

January 10, 2022
·
7 min read
Business

Singular Genomics Partners with Dovetail Genomics to Enable Dovetail Kits for the G4 Sequencing Platform

Singular Genomics Systems, Inc. announced a partnership with Dovetail Genomics to validate its proximity ligation kit portfolio, representing the leading methods to unlock access to 3-D genome architecture, with the G4 sequencing platform.

January 10, 2022
·
4 min read